Mark Leong, executive chairman of Osteopore, says, “ We are pleased to be collaborating with the Livingstone Health orthopaedic team and leverage their expertise to bring our proven tissue regeneration technology to their patients. We look forward to entering the orthopaedic space in Singapore hav...

Healthcare specialist Livingstone Health Holdings has reported earnings of $3.02 million for the FY2022 ended March, reversing from the loss of $16.7 million in the FY2021, or 15 months ended March 31, 2021.The previous year’s net loss included some $20.3 million in non-recurring reverse takeover ...

Upon the issuance of the deferred consideration shares, Livingstone Health’s issued share capital base will be enlarged to approximately 436.4 million shares from 318.9 million shares.

Livingstone Health announced, on March 8, that it has entered into a memorandum of understanding (MOU) with National Phytopharma Joint Stock Company and Truth Assets Management to evaluate healthcare projects opportunities in Vietnam. The agreement was signed on Feb 25 and witnessed by Vietnam presi...

LIVINGSTONE Health Holding has tied up with the National Phytopharma Joint Stock Company and Truth Assets Management (S)(TAM) to evaluate healthcare project opportunities in Vietnam.

SAC Capital is initiating coverage on diversified medical group Livingstone Health with a ‘hold’ call and target price of 16.8 cents. This gives the counter a free float of 25% and is up 2.1 cents from its current 14.7 cent price, analyst Peggy Mak writes in a Feb 3 note. “Our DCF (discounte...

SAC Capital has initiated coverage on Catalist-listed healthcare group Livingstone Health Holdings (LHH) with a "hold" call and a target price of S$0.168 on expected reopening recovery of the medical industry and improved employment.

BEING appointed to lead Sinovac procurement for Singapore's private healthcare institutions might be seen as something of a coup for Livingstone Health Holdings. But chief executive officer Wilson Tay does not wish to overstate the significance of that Covid-19 vaccine's contributi...

LIVINGSTONE Health Holdings posted a 56 per cent rise in net profit to S$2.1 million for its first half ended Sep 30, from S$1.3 million a year ago.

THE following companies saw new developments that may affect trading of their securities on Tuesday (Nov 2):

Livingstone Health Holdings has reported earnings of $2.05 million for the 1HFY2022 ended September, 56% higher than earnings of $1.3 million in the same period before. Earnings per share (EPS) stood at 0.65 cent on a diluted basis, up from 0.42 cent in the 1HFY2021. This is the first set of half-ye...

Livingstone Health Holdings says it has been appointed by the Ministry of Health (MOH) to lead the procurement of Sinovac Biotech’s vaccine on behalf of private healthcare institutions in Singapore. The company has been granted approval to import and supply the vaccines via the special access rout...

THE wholly-owned subsidiary of Livingstone Health Holdings, Livingstone Health International, has been appointed by the Ministry of Health (MOH) to lead the procurement of Sinovac Biotech Covid-19 vaccines on behalf of private healthcare institutions in Singapore.

THE following companies saw new developments that may affect trading of their securities on Wednesday:

Many new companies are getting listed via an RTO deal instead of an IPO. What are its pros and cons of a backdoor listing? There appears to be a dearth of new listings on the Singapore Exchange (SGX). However, IPO numbers alone do not tell the whole story. A constant stream of new companies are tryi...